top of page
< Back

G

PAR-24-296

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

This grant supports early-career research scientists from low- or middle-income countries (LMICs) who hold junior faculty roles. It provides 3-5 years of funding and protected time for research, without leading clinical trials. The goal is to help them build independent research careers focused on health priorities in their countries, with mentorship from both LMIC and U.S. experts.

Full Description

this funding opportunity announcement (foa) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. applicants to this foa are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion foa par-.the purpose of the fogarty emerging global leader award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (lmic) who holds a junior faculty position at an lmic academic or research institution, as defined by the world bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups , including low-income, lower-middle-income, and upper-middle-income countries). this intensive, mentored research career development experience is expected to lead to an independently funded research career at the lmic institution or in another lmic. this funding opportunity announcement (foa) invites applications from lmic scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of lmic and u.s. mentors.

If you want to feel more confident about your application, we're here. Reach out anytime!

Agency:

Contact:

Deadline:

National Institutes of Health

2026-12-03

bottom of page